clinicaltrials.gov
Get the latest updates from ClinicalTrials.gov: Mirikizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days directly as they happen.
The feed address is https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=Mirikizumab&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000. Paste it into any RSS reader, or click Follow now to read it in Feeder.
ClinicalTrials.gov: Mirikizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days posts about 3 times a week. The last post was 6 days ago.
Yes. Feeder checked it 37 minutes ago and the feed answered normally.
Click Follow now, and sign up if you have no account yet. Feeder's free plan covers up to 200 feeds, on the web, iPhone and Android. No credit card required.
Feeder's free plan covers up to 200 feeds, on the web, iPhone and Android. No credit card required.